EU Council Decision 2018/747/EU deals with N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). 

EU Council Decision 2018/748/EU deals with 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA).

ADB-CHMINACA and CUMYL-4CN-BINACA are synthetic cannabinoids with similar effects to those of THC, which is responsible for the major psychoactive effects of cannabis, but they have additional life-threatening toxicity.  The Decisions follow a risk assessment report on each of the new psychoactive substances and require control measures to be put into effect across the EU, as provided for under their national legislation, in compliance with their obligations under the 1971 UN Convention on Psychotropic Substances, and by 23rd May 2019.

Author: raytodd2017

Chartered Legal Executive and former senior manager with Isle of Man Customs and Excise, where I was (amongst other things) Sanctions Officer (for UN/EU sanctions), Export Licensing Officer and Manager of the Legal-Library & Collectorate Support Section

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: